Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection.
Monaghan TM, Negm OH, MacKenzie B, Hamed MR, Shone CC, Humphreys DP, Acharya KR, Wilcox MH. Monaghan TM, et al. Among authors: mackenzie b. Clin Exp Gastroenterol. 2017 Jul 19;10:169-175. doi: 10.2147/CEG.S133939. eCollection 2017. Clin Exp Gastroenterol. 2017. PMID: 28765714 Free PMC article.
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.
Negm OH, MacKenzie B, Hamed MR, Ahmad OAJ, Shone CC, Humphreys DP, Ravi Acharya K, Loscher CE, Marszalowska I, Lynch M, Wilcox MH, Monaghan TM. Negm OH, et al. Among authors: mackenzie b. Clin Exp Immunol. 2017 Jun;188(3):437-443. doi: 10.1111/cei.12946. Epub 2017 Mar 16. Clin Exp Immunol. 2017. PMID: 28213939 Free PMC article.
A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.
Davies NL, Compson JE, Mackenzie B, O'Dowd VL, Oxbrow AK, Heads JT, Turner A, Sarkar K, Dugdale SL, Jairaj M, Christodoulou L, Knight DE, Cross AS, Hervé KJ, Tyson KL, Hailu H, Doyle CB, Ellis M, Kriek M, Cox M, Page MJ, Moore AR, Lightwood DJ, Humphreys DP. Davies NL, et al. Among authors: mackenzie b. Clin Vaccine Immunol. 2013 Mar;20(3):377-90. doi: 10.1128/CVI.00625-12. Epub 2013 Jan 16. Clin Vaccine Immunol. 2013. PMID: 23324518 Free PMC article.
The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.
Clargo AM, Hudson AR, Ndlovu W, Wootton RJ, Cremin LA, O'Dowd VL, Nowosad CR, Starkie DO, Shaw SP, Compson JE, White DP, MacKenzie B, Snowden JR, Newnham LE, Wright M, Stephens PE, Griffiths MR, Lawson AD, Lightwood DJ. Clargo AM, et al. Among authors: mackenzie b. MAbs. 2014 Jan-Feb;6(1):143-59. doi: 10.4161/mabs.27044. MAbs. 2014. PMID: 24423622 Free PMC article.
Biodiversity impacts of the 2019-2020 Australian megafires.
Driscoll DA, Macdonald KJ, Gibson RK, Doherty TS, Nimmo DG, Nolan RH, Ritchie EG, Williamson GJ, Heard GW, Tasker EM, Bilney R, Porch N, Collett RA, Crates RA, Hewitt AC, Pendall E, Boer MM, Gates J, Boulton RL, Mclean CM, Groffen H, Maisey AC, Beranek CT, Ryan SA, Callen A, Hamer AJ, Stauber A, Daly GJ, Gould J, Klop-Toker KL, Mahony MJ, Kelly OW, Wallace SL, Stock SE, Weston CJ, Volkova L, Black D, Gibb H, Grubb JJ, McGeoch MA, Murphy NP, Lee JS, Dickman CR, Neldner VJ, Ngugi MR, Miritis V, Köhler F, Perri M, Denham AJ, Mackenzie BDE, Reid CAM, Rayment JT, Arriaga-Jiménez A, Hewins MW, Hicks A, Melbourne BA, Davies KF, Bitters ME, Linley GD, Greenville AC, Webb JK, Roberts B, Letnic M, Price OF, Walker ZC, Murray BR, Verhoeven EM, Thomsen AM, Keith D, Lemmon JS, Ooi MKJ, Allen VL, Decker OT, Green PT, Moussalli A, Foon JK, Bryant DB, Walker KL, Bruce MJ, Madani G, Tscharke JL, Wagner B, Nitschke CR, Gosper CR, Yates CJ, Dillon R, Barrett S, Spencer EE, Wardle GM, Newsome TM, Pulsford SA, Singh A, Roff A, Marsh KJ, Mcdonald K, Howell LG, Lane MR, Cristescu RH, Witt RR, Cook EJ, Grant F, Law BS, Seddon J, Berris KK, Shofner RM, Barth M, Welz T, Foster A, Hancock D, Beitzel … See abstract for full author list ➔ Driscoll DA, et al. Among authors: mackenzie bde. Nature. 2024 Nov;635(8040):898-905. doi: 10.1038/s41586-024-08174-6. Epub 2024 Nov 13. Nature. 2024. PMID: 39537920 Free PMC article.
Genetic Sex and Origin Identification Suggests Differential Migration of Male and Female Atlantic Bluefin Tuna (Thunnus thynnus) in the Northeast Atlantic.
Nielsen EE, Birnie-Gauvin K, Baktoft H, Arrizabalaga H, Brodin T, Cardinale M, Casini M, Helström G, Jansen T, Koed A, Lundberg P, MacKenzie BR, Medina A, Post S, Rodriguez-Ezpeleta N, Sundelöf A, Varela JL, Aarestrup K. Nielsen EE, et al. Among authors: mackenzie br. Evol Appl. 2024 Sep 19;17(9):e70009. doi: 10.1111/eva.70009. eCollection 2024 Sep. Evol Appl. 2024. PMID: 39301501 Free PMC article.
Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis.
MacKenzie B, Mahavadi P, Jannini-Sa YAP, Creyns B, Coelho AL, Espindola M, Ruppert C, Hötzenecker K, Hogaboam C, Guenther A. MacKenzie B, et al. bioRxiv [Preprint]. 2024 Apr 28:2024.04.24.589970. doi: 10.1101/2024.04.24.589970. bioRxiv. 2024. PMID: 38712072 Free PMC article. Preprint.
Caveolin scaffolding domain (CSD) peptide LTI-2355 modulates the phagocytic and synthetic activity of lung derived myeloid cells in Idiopathic Pulmonary Fibrosis (IPF) and Post-acute sequelae of COVID-fibrosis (PASC-F).
Creyns B, MacKenzie B, Sa Y, Coelho AL, Christensen D, Parimon T, Windsor B, Hogaboam CM. Creyns B, et al. Among authors: mackenzie b. bioRxiv [Preprint]. 2024 Jan 16:2023.12.01.569608. doi: 10.1101/2023.12.01.569608. bioRxiv. 2024. PMID: 38654821 Free PMC article. Preprint.
221 results